To generate the atlas, scientists used a bioorthogonal proteomics strategy to tag and track the progress of over 800 proteins in the blood.

A new hybrid mechanistic-data-driven model of lactate consumption and production for mammalian cell cultures captures both ...

Detailed cell atlas indicates that important biological features associated with invasive breast cancer begin to emerge earlier than previously known.

Currus Bio cites support from Lonza and Octane Biotech as key to efforts to automate production of its candidate cancer cell therapy, CUR-001.

Computer-designed protein therapeutics move from proof-of-concept to wet-lab validation and even clinical trials as the field ...

Discovery offers new insights into the processes that drive cell proliferation and may influence cancer growth, and could ...

Argenx has agreed to acquire Unnatural Products (UNP) for up to $1.15 billion, more than a year after they began partnering ...

Novartis has confirmed nine instances—seven of them newly disclosed—in which tumors have developed in children treated with its marketed spinal muscular atrophy gene therapy Zolgensma® (onasemnogene ...

Illumina's early access duplex sequencing workflow for MRD and tumor evolution research pairs NovaSeq X with DRAGEN to support the detection of trace ctDNA in plasma.

Nurix Therapeutics suffered its worst one-day loss as a public company Wednesday, nosediving 38% after Sanofi terminated ...

The work could lead to new ways of treating pediatric tumors that aim to stop cancer cells from entering states that make them dangerous.

Personalized grafts, bioinks, and off-the-shelf tissues are advancing regenerative medicine toward broader clinical use.